Citius Pharmaceuticals, Inc. announced that Dr. John Laffey has been appointed to its ARDS Scientific Advisory Board (SAB), effective immediately. Dr. John Laffey is Professor of Anesthesia and Intensive Care Medicine at the School of Medicine of the National University of Ireland (NUI Galway), and a Consultant in Anesthesia and Intensive Care Medicine at Galway University Hospitals. He is Director of Clinical Research at Saolta Hospital Group and NUI Galway. Dr. Laffey's primary focus is on the investigation of therapeutic strategies for ARDS. He founded and leads the lung biology group at NUI Galway. His research groups are currently conducting studies into the pathogenesis of ventilation induced lung injury and sepsis induced Acute Lung Injury. The current focus of his research is on the investigation of the therapeutic potential of gene and stem cell-based therapies for acute lung injury.